Wellington Management Group’s Q32 Bio QTTB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-33,776
Closed -$2.21M 2247
2021
Q4
$2.21M Sell
33,776
-9,680
-22% -$940K ﹤0.01% 1638
2021
Q3
$6.16M Sell
43,456
-89,468
-67% -$11.4M ﹤0.01% 1439
2021
Q2
$17.4M Buy
132,924
+6,373
+5% +$795K ﹤0.01% 1125
2021
Q1
$21.4M Buy
126,551
+7,496
+6% +$1.58M ﹤0.01% 1052
2020
Q4
$24.2M Buy
119,055
+35,343
+42% +$6.83M ﹤0.01% 994
2020
Q3
$16.1M Buy
83,712
+60,672
+263% +$13.6M ﹤0.01% 994
2020
Q2
$6.3M Buy
+23,040
New +$6.14M ﹤0.01% 1169
2020
Q1
Sell
-25,042
Closed -$9.33M 2071
2019
Q4
$9.33M Buy
+25,042
New +$7.17M ﹤0.01% 1180
2018
Q2
Sell
-2,074
Closed -$698K 2330
2018
Q1
$698K Buy
+2,074
New +$697K ﹤0.01% 1960

Other funds holding QTTB

Wellington Management Group's QTTB Position: Q1 2022 in Review

Wellington Management Group sold out of Q32 Bio (QTTB) in Q1 2022, closing a stake of 33,776 shares — an estimated $2.21M sold.

Wellington Management Group first reported a position in QTTB in Q1 2018 and held it in 9 quarters. The position peaked at $24.2M in Q4 2020. 106 funds tracked by Wall St. Rank hold QTTB as of Q1 2022.

  • Wellington Management Group reported no remaining Q32 Bio position as of Q1 2022 after selling out during the quarter.
  • Wellington Management Group sold 33,776 Q32 Bio shares in Q1 2022, an estimated $2.21M.
  • Wellington Management Group first reported a position in Q32 Bio in Q1 2018 and held it in 9 quarters.
  • Wellington Management Group's Q32 Bio position peaked at $24.2M in Q4 2020.
  • 106 funds tracked by Wall St. Rank held Q32 Bio as of Q1 2022.

Based on Wellington Management Group's 13F filing for Q1 2022, filed 16 May 2022.